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A commentary on
Does Cognitive Behavior Therapy for psychosis (CBTp) show a sustainable effect on delusions?
A meta-analysis
by Mehl, S., Werner, D., and Lincoln, T. M. (2015). Front. Psychol. 6:1450. doi:
10.3389/fpsyg.2015.01450
In their meta-analysis, Mehl et al. (2015) examine whether CBT for psychosis is an effective
intervention for reducing delusions. The authors reported a small but significant effect size for CBT
in comparison to TAU at end-of-therapy (k = 13; d = 0.27) and at follow-up (k = 12; d = 0.25).
By contrast, no significant benefit emerged for CBT when compared to active control conditions
either at end-of-therapy (k = 8; d = 0.16) or at follow-up (k = 5; d = −0.04). The meta-analysis,
however, contains errors and omissions that when rectified, cast doubt on the reliability of the
reported significant effects comparing CBT to Treatment as Usual (TAU) at end-of treatment and
at follow-up.
First, for the end-of-trial analysis, Mehl et al. demonstrate the presence of significant publication
bias. Their funnel plot is asymmetric and a trim-and-fill analysis points to four possible missing
unpublished studies (a large number when only 13 RCTs studies were analyzed). They note that
when effect sizes for the four “missing” studies are included, the original effect size almost halves
from d = 0.27 to d = 0.14. Mehl et al. did not, however, report the 95% Confidence Intervals and
whether the revised effect size is significant (rather they report the standard error: SE= 0.12)—the
required analysis reveals that the revised effect size of 0.14 becomes non-significant (95%CI −0.07
to 0.35).
Second, Mehl et al. also highlight the moderate level of heterogeneity in their end-of-trial
analysis and attribute this to one outlying study by Kråkvik et al. (2013). After removing Kråkvik
et al. they report that heterogeneity reduces with I2 falling from 42 to 11.7%. Key information
concerning the revised effect size is, however, missing. A random effects recalculation shows that
removal of Kråkvik reduces the effect size from 0.27 to 0.19 (95% CI 0.03 to 0.35), which is small
but significant; however re-calculation of I2 did not seem to fall to 11.7% but 21.6%. Whatever the
reduction in the percentage of I2, the key point here, is why Krakvik (d = 0.94) alone is considered
an outlier, but not Foster (d = 0.90) or Waller et al. (d = 0.89). The removal of a single outlier here
is somewhat opaque and atheoretical.
Third, Mehl et al. give only a fleeting mention to the most well-documented, “genuine” and
significant source of heterogeneity in CBTp trials—whether outcomes are measured blind or not
(see Lynch et al., 2010; Jauhar et al., 2014). Indeed, the issue of blinding pertains both to the issue
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of Kråkvik et al. and the asymmetric funnel plot mentioned
above. Mehl et al. state that “Only one of these studies did not
use single-blind assessment (Foster et al., 2010)”; however, it is
clear that Mehl and colleagues misclassify two non-blind trials
as blind. In their discussion, Mehl et al. note that Kråkvik et al.
(2013) “produced a quite large effect size (d = 0.94), which
might also have been influenced by difficulties in maintaining
the blinding procedure.” If we turn to the Kråkvik et al paper
itself, those authors clearly state that “All four professionals were
trained in the use of assessment measures, but it was not possible
to keep them blind to the treatment condition.” Mehl et al. also
incorrectly classify Waller et al. (2015) as a blind trial when it was
non-blind. These 3 of 13 non-blind trials (Foster 0.90; Kråkvik
0.94; Waller 0.89) produced the largest effects reported for CBT
on delusions. Further analysis of Mehl et al.’s data shows that
blind trials (k = 9) elicit a non-significant effect size of d = 0.13
(95% CI −0.028 to 0.29) while non-blind trials (K = 4 adding
Lincoln, which is self-rating) produce an effect size five-times
larger with d = 0.65 (95% CI 0.21 to 1.09). Additionally, it
is notable that amongst the nine blind trials, heterogeneity is
virtually non-existent I2= 4.8. In sum, the minority of non-blind
trials underpins the inflation of effect sizes and their reported
heterogeneity.
Turning to the follow-up analysis, where Mehl et al. claim an
overall significant effect of CBT on delusions with d = 0.25. Their
analysis reports a significant effect size of 0.43 for Turkington
et al. (2006) which is the largest sample included and hence most
heavily weighted effect size in their meta-analysis. This effect
size is, however, difficult to reconcile with the data presented
in the Turkington paper itself- where the Psychotic Symptom
Rating Scale (PSYRATS: Haddock et al., 1999) delusion score
was not only non-significant, but in the opposite direction—
with a greater decrease of delusions in controls than CBT
(confirmed in personal communication by one of the authors).
A recalculation using the Turkington data reveals an effect size
of d = −0.11 (−0.33 to 0.11) in favor of controls. If we add
this new value to replace the apparently erroneous effect size
reported by Mehl et al. a random effects model now shows the
overall effect size reduces to 0.16 (−0.03 to 0.34) and becomes
non-significant.
To summarize, examination of Mehl et al.’s end-of-trial data
comparing CBT and TAU shows that if the overall effect size
is adjusted for potential publication bias, then it becomes non-
significant. Further analysis of the same data also shows that
the significant heterogeneity reported by Mehl et al. is likely to
reflect the inclusion of 4 non-blind trials, which elicit effects sizes
five-times larger than in blinded trials. Analysis of nine blind
trials revealed no heterogeneity and no CBT efficacy. Turning to
the follow-up data, adjusting the effect size for Turkington et al.
(2006) means the overall CBT efficacy becomes non-significant.
In other words, CBT fails to reduce delusional thinking compared
to “active” controls at either end-of-trial or at follow-up, and
further fails to reduce delusional thinking when compared to
TAU at follow-up and shows no efficacy at end-of-trial except
where there is high risk of bias.
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